A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Cornfeld, MD
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
52 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lkh Graz
Graz, Austria
- Medizinische Universitat Innsbruck
Innsbruck, Austria
- Ordensklinikum
Linz, Austria
- Universitatsklinikum St. Polten
Sankt Pölten, Austria
- Institut Bergonié
Bordeaux, France
- Cepcm / Chu Timone
Marseille, France
- Institut Paoli Calmettes
Marseille, France
- Georges Pompidou European Hospital
Paris, France
- Hopitaux Universitaires de Strasbourg
Strasbourg, France
- Baz County Hospital
Miskolc, Hungary
- Hetenyi G Korhaz, Onkologiai Kozpont
Szolnok, Hungary
- Azienda Ospedaliera Universitaria Ospedali Riuniti Di Ancona
Ancona, Italy
- Asst Istituti Ospitalieri
Cremona, Italy
- Istituto Scientifico Romagnolo Per Lo Studio E la Cura Dei Tumori
Meldola, Italy
- Istituto Nazionale Tumori Regina Elena
Rome, Italy
- Azienda Ospedaliera Universitaria Senese
Siena, Italy
- Med-Polonia Sp. Z O. O.
Poznan, Greater Poland Voivodeship, Poland
- Centrum Onkologii- Instytut Im Marii Skłodowskiej Curie
Warsaw, Masovian Voivodeship, Poland
- Specjalistyczna Praktyka Lekarska
Lublin, Poland
- Biovirtus Research Site
Otwock, Poland
- Centrul de Oncologie Sfantul Nectarie
Craiova, Dolj, Romania
- Oncolab Srl
Craiova, Dolj, Romania
- Medisprof Srl
Cluj-Napoca, Romania
- Clinical Emergency Hospital of Constanta
Constanța, Romania
- Center of Oncology Euroclinic
Iași, Romania
- Spitalul Clinic Judetean de Urgenta Sibiu
Sibiu, Romania
- Oncocenter - Oncologie Clinica Srl
Timișoara, Romania
- Hospital Universitari Parc Tauli
Sabadell, Barcelona, Spain
- Centro Oncologico de Galicia
A Coruña, Spain
- Hospital Universitario Vall D'Hebron
Barcelona, Spain
- Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
- Md Anderson Cancer Center Madrid
Madrid, Spain
- Hospital Puerta de Hierro
Majadahonda, Spain
- Hospital Universitari la Fe
Valencia, Spain
- California Cancer Associates for Research and Excellence
Fresno, California, United States
- California Cancer Associates for Research and Excellence, Inc.
Fresno, California, United States
- California Cancer Associates for Research and Excellence, Inc.
San Marcos, California, United States
- St Joseph Heritage Healthcare
Santa Rosa, California, United States
- St. Joseph Health Medical Group - Annadel Medical Group
Santa Rosa, California, United States
- Rocky Mountain Cancer Centers - Denver - Midtown
Denver, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Jan 2019
- Primary completion
- 15 Apr 2021
- Completion
- 28 Jun 2022
- Last update posted
- 21 Jul 2023
- Registered enrollment
- 121
- Registry id
- NCT03679767
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.